What is the latest MANIPALHOS stock price?
The latest stored price for MANIPALHOS is Rs 701.30 as of 2026-10-09.
gimli
MANIPALHOS stock AI analysis
MANIPALHOS Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
MANIPAL HEALTH ENTERPRI L is a small-cap stock in Healthcare. This Gimli page shows the latest available MANIPALHOS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹701.30
1W return
+0.76%
1M return
-3.92%
3M return
n/a
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
+8.76%
ROCE
+10.64%
RSI
46.66
Turnover
₹97.61 cr
Why it can matter in screens
- Momentum: MANIPALHOS is below 50DMA, below 200DMA; RSI is 46.66.
- Returns: 1D +2.52%, 1W +0.76%, 1M -3.92%, 3M n/a, 1Y n/a.
- Trend levels: 52W high ₹815.00, 52W low ₹625.45, off high -13.95%.
- Liquidity: latest turnover is ₹97.61 cr; volume vs 20D is +1.40%.
- Valuation/profitability: PE n/a, PB n/a, ROE +8.76%, ROCE +10.64%.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Quick Answers
Is MANIPALHOS above its 50DMA and 200DMA?
MANIPALHOS is below 50DMA, below 200DMA. The latest 50DMA is n/a and the latest 200DMA is n/a.
What are MANIPALHOS PE, ROE and ROCE?
MANIPALHOS has PE n/a, ROE +8.76%, and ROCE +10.64% in Gimli's latest available snapshot.
How has MANIPALHOS performed recently?
MANIPALHOS has returned -3.92% over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 10,935.62 cr | 2,834.87 cr | 654.93 cr | nan |
| 2025-03-31 | 9,263.56 cr | 2,455.03 cr | 512.96 cr | 3.90 |
| 2024-03-31 | 6,079.39 cr | 1,546.86 cr | 594.32 cr | 4.52 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 24,864.50 cr | 299.35 cr | 12,863.06 cr | 8,798.76 cr |
| 2025-03-31 | 21,443.81 cr | 976.96 cr | 11,900.83 cr | 6,160.29 cr |
| 2024-03-31 | 10,818.83 cr | 360.88 cr | 5,130.24 cr | 4,087.51 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 2,078.40 cr | 762.21 cr | n/a |
| 2025-03-31 | 1,569.83 cr | 515.52 cr | n/a |
| 2024-03-31 | 1,388.64 cr | 1,056.71 cr | n/a |
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 422,282.96 cr | 34.857273 | +15.50% | +6.12% |
| DIVISLAB | DIVI S LABORATORIES LTD | 247,947.67 cr | 85.088426 | +18.37% | +52.32% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,610.64 cr | 72.265309 | +17.33% | +31.16% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 115,423.17 cr | 58.937484 | +21.03% | +4.32% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 112,446.65 cr | 25.058308 | +16.04% | +12.37% |
| LAURUSLABS | LAURUS LABS LIMITED | 109,947.20 cr | 100.670416 | +21.77% | +135.42% |
| CIPLA | CIPLA LTD | 105,094.85 cr | 31.162389 | +10.25% | -14.02% |
| DRREDDY | DR. REDDY S LABORATORIES | 99,661.60 cr | 30.096514 | +9.23% | -3.94% |
Try these prompts
- Analyze MANIPAL HEALTH ENTERPRI L with valuation, momentum and industry peers
- Compare MANIPALHOS with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare MANIPALHOS with other Healthcare stocks
Data snapshot: 2026-10-09. Not investment advice.